Jupiter Life Line Hospitals Share Price Target 2025, 2026, 2030, 2040, 2050

It is a well-known hospital group in Western India, with major hospitals in Thane, Pune, and Indore, founded by Dr Ajay Thakker, and it started operations in 2007. The company provides many types of medical care, from basic treatment to difficult surgeries and organ transplants. It offers services in more than 30 medical areas, such as heart care, cancer treatment, brain and nerve care, and advanced transplants, using modern equipment and experienced doctors. Each hospital works as a full-service centre that can manage advanced treatments on its own.

What is Jupiter Life Line Hospitals Ltd NSE: JLHL?

Jupiter Life Line Hospitals was established in 2002, established in Mumbai, Maharashtra, and founded by Dr Ajay Pratap Thakker. It is an Indian hospital group that runs multi-speciality hospitals. It provides many healthcare services, from basic check-ups to advanced surgeries, including heart treatment, cancer care, bone and joint care, brain and nerve treatment, and organ transplants. The company runs major hospitals in Thane, Pune, and Indore, with modern facilities and experienced doctors. Its main aim is to give good quality treatment, keep patients safe, and grow its hospitals in growing Indian cities.

Jupiter Life Line Hospitals Share Price Target

Jupiter Life Line Hospitals Share Price Target 2025

Jupiter Life Line Hospitals Ltd. is a well-known hospital company in India that runs large multi-speciality hospitals under the Jupiter name. The company provides both basic medical care and advanced treatment in a safe and caring environment. Jupiter hospitals treat many health problems, from small illnesses to serious and life-threatening diseases. The company follows a patient-first approach, which means the comfort, safety, and proper treatment of patients always come first. In 2025, its share price target would be ₹1770, as per stock market analysts.

According to stock market analysts, its share price would be between ₹1266 to ₹1770 in 2025.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2025	1266	1770

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	1467	1648
February	1410	1706
March	1403	1770
April	1266	1596
May	1380	1500
June	1400	1556
July	1411	1560
August	1346	1480
September	1400	1550
October	1473	1625
November	1405	1609
December	1294	1658

Jupiter Life Line Hospitals Share Price Target 2026

It was started by Dr Ajay Thakker. His goal was to build hospitals that give high-quality medical care with kindness and respect. He wanted patients to feel safe and well-informed about their treatment. Under his leadership, the hospitals follow honest and fair practices and focus on long-term growth. The management team works closely with doctors and staff to improve hospital services and patient care. In 2026, its share price target would be ₹2248, as per stock market analysts.

According to stock market analysts, its share price would be between ₹1600 to ₹2248 in 2026.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2026	1600	2248

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	1600	1784
February	1632	1820
March	1675	1864
April	1711	1882
May	1735	1900
June	1755	1935
July	1774	1967
August	1790	1990
September	1825	2025
October	1856	2065
November	1874	2125
December	1968	2248

Share Price Target 2027

It runs major hospitals in Thane and Pune in Maharashtra, and Indore in Madhya Pradesh. These cities have large populations and a growing need for good healthcare services. Each hospital is in an easy-to-reach location, so patients can arrive quickly in emergencies. The hospitals are large and can treat many patients every day. The company helps people who earlier did not have easy access to advanced medical care. In 2027, its share price target would be ₹2731, as per stock market analysts.

According to stock market analysts, its share price would be between ₹2187 to ₹2731 in 2027.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2027	2187	2731

Share Price Target 2028

It offers treatment in more than 30 medical areas, making it a true multi-speciality hospital group. These include heart care, cancer treatment, bone and joint care, brain and nerve treatment, kidney care, stomach and digestion care, women’s health, and children’s care. Patients can see different specialist doctors in the same hospital, which makes treatment easier and faster. Doctors from different departments work together, especially for serious cases, to give better results. In 2028, its share price target would be ₹3203, as per stock market analysts.

According to stock market analysts, its share price would be between ₹2678 to ₹3203 in 2028.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2028	2678	3203

Share Price Target 2029

Every decision is made by thinking about the patient’s comfort, safety, and health. Doctors explain health problems and treatment options in simple words so patients can understand easily. Nurses and hospital staff are trained to be kind, helpful, and respectful. The hospital environment is clean and calm to reduce fear and stress. From the time a patient comes to the hospital until they leave, the focus is on giving caring and smooth service so patients and families feel supported. In 2029, its share price target would be ₹3661, as per stock market analysts.

According to stock market analysts, its share price would be between ₹3137 to ₹3661 in 2029.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2029	3137	3661

Jupiter Life Line Hospitals share price Target 2030

It follows an all-hub-no-spoke model. This means each hospital works as a full medical centre on its own. Every hospital has its own operating theatres, testing labs, intensive care units, and recovery services. Patients do not need to go to another Jupiter hospital for advanced treatment. This system saves time and allows quick care during emergencies. It also makes sure that every hospital can handle serious and difficult cases by itself, making treatment easier for patients. In 2030, its share price target would be ₹4114, as per stock market analysts.

According to stock market analysts, its share price would be between ₹3580 to ₹4114 in 2030.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2030	3580	4114

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	3580	3800
February	3625	3841
March	3665	3874
April	3715	3890
May	3751	3925
June	3787	3955
July	3800	3978
August	3835	4000
September	3874	4032
October	3890	4058
November	3932	4087
December	3978	4114

Share Price Target 2040

It uses modern medical technology to give better care. Advanced scan machines, digital patient records, and special medical equipment help doctors find health problems early and treat them correctly. Some surgeries use robotic machines to improve accuracy and help patients recover faster. Technology is also used to closely watch patients and plan treatment better. In 2040, its share price target would be ₹6795, as per stock market analysts.

According to stock market analysts, its share price would be between ₹6307 to ₹6795 in 2040.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2040	6307	6795

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	6307	6478
February	6321	6500
March	6345	6541
April	6375	6578
May	6390	6590
June	6412	6632
July	6433	6658
August	6458	6684
September	6484	6715
October	6515	6754
November	6535	6780
December	6587	6800

Share Price Target 2050

It mainly focuses on cities and nearby areas where the need for healthcare is growing quickly. Many of these places earlier did not have advanced hospitals. By building large multi-speciality hospitals in such areas, the company helps people get quality treatment closer to their homes. This reduces long travel for patients and helps in emergencies. The company is also growing its hospital network. In 2050, its share price target would be ₹9267, as per stock market analysts.

According to stock market analysts, its share price would be between ₹8812 to ₹9267 in 2050.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2050	8812	9267

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	8812	8950
February	8847	8987
March	8878	9025
April	8890	9045
May	8912	9075
June	8935	9090
July	8945	1024
August	8965	1042
September	8978	1057
October	8990	1078
November	9021	1090
December	9050	1135

Should I buy Jupiter Life Line Hospitals stock?

Year	Minimum Price (Rs)	Maximum Price (Rs)
2025	1266	1770
2026	1600	2248
2027	2187	2731
2028	2678	3203
2029	3137	3661
2030	3580	4114
2040	6307	6795
2050	8812	9267

The company is growing, has strong hospitals, and is opening new ones like the Dombivli hospital. More people in India need healthcare every year, which can help the company earn more in the future. Its stock is good for long-term investment, but in the short term, profits may not increase quickly because running hospitals costs a lot of money. So, buy this stock only if you can keep it for many years. If you want quick profits or low risk, it is better to wait or not buy it now.

Jupiter Life Line Hospitals earnings results

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales +	463	486	733	893	1,073	1,262	1,395
Expenses +	379	419	580	691	831	965	1,070
Operating Profit	84	67	153	201	242	297	325
OPM %	18%	14%	21%	23%	23%	24%	23%
Other Income +	0	4	4	8	22	29	38
Interest	26	39	44	42	26	11	24
Depreciation	26	31	36	39	42	57	74
Profit before tax	33	2	77	129	195	258	265
Tax %	10%	248%	34%	43%	10%	25%
Net Profit +	30	-2	51	73	177	194	199
EPS in Rs	5.83	-0.45	10.05	12.90	26.94	29.51	30.27
Dividend Payout %	0%	0%	0%	0%	4%	3%

Key Metrics

TTM PE Ratio	PB Ratio	Dividend Yield	Sector PE	Sector PB	Sector Div Yld
46.57	6.82	0.07%	36.54	5.77	0.59%

Peers & Comparison

Stock	PE Ratio	PB Ratio	Dividend Yield
Jupiter Life Line Hospitals Ltd	47.78	6.82	0.07%
Max Healthcare Institute Ltd	98.14	11.26	0.14%
Apollo Hospitals Enterprise Ltd	70.47	9.18	0.18%
Fortis Healthcare Ltd	84.82	7.16	0.11%

Is Jupiter Life Line Hospitals stock good to buy? (bull case & bear case)

Bull Case:

• In Q2 FY2025‑26, revenue grew ~17–18% to ₹393–₹405 crore, and net profit went up ~11% to ₹57 crore.
• In Q3 FY2025, revenue grew ~18% YoY, and net profit jumped ~30%, showing steady growth.
• More people in India need hospital services, which supports long-term growth.
• New hospitals in Dombivli and Pune can bring more patients and revenue.
• Q2 net profit rose ~30% compared to Q1 FY2025‑26, showing strong growth from the previous quarter.
• In FY2024‑25, sales grew ~18% to ₹1,261 crore, and net profit increased ~10% to ₹193 crore.
• Higher occupancy and better hospital efficiency can improve profits over time.

Bear Case:

• Net profit margins in Q2 FY2025‑26 fell slightly due to rising costs.
• High expenses for staff, machines, and new hospitals can reduce short-term profits.
• Competition from other hospital chains may slow growth.

Conclusion

It provides basic to advanced care, including surgeries and organ transplants, in over 30 specialities. With rising healthcare demand, new hospitals, and better efficiency, the company has strong long-term growth potential. Short-term profits may be affected by high costs and competition, but the stock is suitable for long-term investors.

FAQs